Xenetic Biosciences Correlations
XBIO Stock | USD 3.64 0.13 3.45% |
A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Xenetic Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Xenetic Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Xenetic Biosciences Correlation With Market
Modest diversification
The correlation between Xenetic Biosciences and DJI is 0.23 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Xenetic Biosciences and DJI in the same portfolio, assuming nothing else is changed.
Xenetic |
Moving together with Xenetic Stock
0.68 | IMMX | Immix Biopharma | PairCorr |
0.67 | MNOV | MediciNova | PairCorr |
0.64 | MOLN | Molecular Partners | PairCorr |
0.7 | NKTX | Nkarta Inc | PairCorr |
0.66 | PHVS | Pharvaris BV | PairCorr |
0.67 | RGNX | Regenxbio | PairCorr |
0.66 | ABOS | Acumen Pharmaceuticals | PairCorr |
0.63 | APLS | Apellis Pharmaceuticals | PairCorr |
Moving against Xenetic Stock
0.51 | LLY | Eli Lilly | PairCorr |
0.41 | PFE | Pfizer Inc Sell-off Trend | PairCorr |
0.37 | MGTX | MeiraGTx Holdings PLC Earnings Call Tomorrow | PairCorr |
0.34 | IVA | Inventiva Sa | PairCorr |
0.61 | ABBV | AbbVie Inc | PairCorr |
0.32 | MDT | Medtronic PLC | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Xenetic Stock performing well and Xenetic Biosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Xenetic Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
RNAZ | 9.98 | (1.55) | 0.00 | (0.54) | 0.00 | 28.00 | 94.32 | |||
LABP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
NEXI | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
ONCR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
ZVSA | 4.46 | 0.00 | 0.02 | 0.00 | 4.63 | 12.03 | 37.54 | |||
IMMX | 3.69 | (0.36) | 0.00 | (1.93) | 0.00 | 9.09 | 26.42 | |||
PHIO | 11.30 | 2.19 | 0.17 | 0.35 | 9.87 | 9.40 | 336.29 | |||
ATNF | 4.59 | (0.55) | 0.00 | (0.53) | 0.00 | 6.73 | 79.11 | |||
NAVB | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
REVB | 6.46 | (1.29) | 0.00 | 1.93 | 0.00 | 17.05 | 71.84 |
Xenetic Biosciences Corporate Executives
Elected by the shareholders, the Xenetic Biosciences' board of directors comprises two types of representatives: Xenetic Biosciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Xenetic. The board's role is to monitor Xenetic Biosciences' management team and ensure that shareholders' interests are well served. Xenetic Biosciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Xenetic Biosciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
James Parslow | CFO, Principal Accounting Officer, Principal Financial Officer | Profile |